Variation of perioperative blood cTnT levels in patients undergoing cardiopulmonary bypass and its clinical implication

Chen Tao , Pan Tiecheng

Current Medical Science ›› 2000, Vol. 20 ›› Issue (3) : 225 -226.

PDF
Current Medical Science ›› 2000, Vol. 20 ›› Issue (3) : 225 -226. DOI: 10.1007/BF02886998
Article

Variation of perioperative blood cTnT levels in patients undergoing cardiopulmonary bypass and its clinical implication

Author information +
History +
PDF

Abstract

The clinical value of cardiac Troponin T (cTnT) as a marker in assessing myocardial cell damage in the patients undergoing open heart surgery was studied. Serum cTnT and CK-MB levels were measured in serial blood samples from 20 patients undergoing open heart surgery before operation, at aorta clamping, aorta opening, the end of CPB and the operation, and subsequently one h, one day, 3 days and one week after operation respectively. Ten patients receiving thoracic surgery were also subjected to the measurement of cTnT and CK-MB before and 24 h after operation. The results showed that peak concentrations were reached earlier in cTnT than in CK-MB, and the circulation cTnT remained high when CK-MB had already decreased to normal. In 10 patients receiving thoracic surgery, cTnT level was normal and CK-MB was increased in 4 patients after surgery. It was concluded that the sensitivity and specificity of cTnT was more than those of CK-MB and cTnT could be used as a routine indicator for myocardiac protection.

Keywords

myocardium protection / troponin T / sensitivity / specificity

Cite this article

Download citation ▾
Chen Tao, Pan Tiecheng. Variation of perioperative blood cTnT levels in patients undergoing cardiopulmonary bypass and its clinical implication. Current Medical Science, 2000, 20(3): 225-226 DOI:10.1007/BF02886998

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

1998, 13(2):72

[2]

T I 1996, 3(4):35

[3]

1998, 19(2):80

[4]

KatusH A, SchoappenthouM, TanzeemA, et al.. Noninvasive assessment of perioperative myocardial cell damage by circulating cardiac troponin T. Br Heart J, 1991, 65: 259-259

[5]

KatusH A, LeserS, HallermayerK, et al.. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem, 1992, 38: 386-386

[6]

MairP, MairJ, SeibtI, et al.. Cardiac troponin T, a new marker of myocardial tissue damage in bypass surgery. J Cardiothorac Vasc Anesth, 1993, 7: 674-674

[7]

TaggartD P, TongV, HopperJ, et al.. Lack of cardioprotective efficacy of allopurinol in coronary artery surgery. Br Heart J, 1994, 71: 77-77

[8]

ChapelleJ P, AllafD E.. Differentiating muscle damage from myocardial injury by means of MB mass measurement/Total CK. Clin Chem, 1986, 32: 291-291

AI Summary AI Mindmap
PDF

109

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/